Real-time enrollment status for this acute leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT04065399 |
| Recruiting Status | Recruiting |
| Condition | Acute Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 413 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Syndax Pharmaceuticals |
| Last Updated on CT.gov | February 17, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT04065399 is currently recruiting participants. This clinical trial study for acute leukemia is actively seeking new participants at 22 locations across the United States. The study is sponsored by Syndax Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04065399 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04065399 was last updated 1 week ago (February 17, 2026). HelloStudys verifies this status automatically.